ABBV says Skyrizi and Rinvoq will have combined worldwide sales of $27B by 2027. I wonder how continued U.S. progression into socialized medicine could impact the estimate. Anyone got a balloon?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.